Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for U
Classification of Orally Administered Drugs on the World Health Organization Model List of Essential Medicines According to the Bio Pharmaceutics Classification System | Bioavailability | Pharmaceutical Drug
Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydro
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g007-550.jpg)
Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML
![Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine | Drug Metabolism & Disposition Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/sites/default/files/highwire/dmd/46/11.cover-source.jpg)
Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine | Drug Metabolism & Disposition
Analytical Profiles of Drug Substances Volume 18 1989 | Acid Dissociation Constant | Differential Scanning Calorimetry
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g002.png)
Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g006.png)